Movie Industry

Director Kim Han-min of ‘The Admiral: Roaring Currents’ Gets Married Late in Life at Age 57… Wedding Set for November 15

The Bride-to-Be Is Pansori Master Lee So-young Party-Style Wedding Held at an Undisclosed Location in Seoul

YUN GI BACK
2026-10-19 15:57:14
[Edaily Starin YUN GI BACK Reporter] Director Kim Han-min, who directed the film “The Admiral: Roaring Currents,” is set to tie the knot this November. He is getting married relatively late in life, at the age of 57.
Director Kim Han-min. (Photo = E-Daily DB)

According to the film industry on the 19th, Director Kim will tie the knot with renowned pansori singer Lee So-young at a hotel in Seoul on the 15th of next month.
Born in 1969, Director Kim made his debut in 1999 with the short film “That’s How Kim Sun-im Met Kang Du-sik.” He subsequently established himself as one of Chungmuro’s leading directors through films such as “The Murder Case in Geukrakdo” and “The Last Archer.”
In particular, his 2014 film “The Admiral: Roaring Currents” drew 17.61 million viewers, setting the all-time box office record for a Korean film. He subsequently released “Hansan: The Rising Dragon” and “Noryang: The Sea of Death” in quick succession, completing the Admiral Yi Sun-sin trilogy.
Director Kim currently serves as the CEO of the film production company Bigstone Pictures and is preparing for the release of his next film, “Kal: The Sword of Godu Makhan.” The film stars Park Bo-gum, Joo Won, Jung Jae-young, and Lee Sun-bin.

Economy

Corporation

IT·Science

Economy

Shin Hyun-song: "Inflation to Exceed 2.5% Next Year… Growth Forecasts for This Year and Next Year Also Revised Upward"

Bank of Korea Governor Shin Hyun-song predicted that next year’s consumer price inflation rate will exceed the previous forecast of 2.5%. He also forecast that economic growth rates for this year and …
2026-10-23 11:22:56

Corporation

Is the Efficacy Announcement a “Predetermined Outcome”?… “Some Indicators Point in the Desired Direction”

Aptabio Therapeutics Inc.(293780)has expressed confidence ahead of the announcement of the efficacy of its kidney disease treatment candidate “Isuzinaxib” (APX-115). This follows the company’s selecti…
2026-10-23 12:02:02

IT·Science

Orum Therapeutics, Inc. Welcomes U.S. BD Expert Back to Board… A Breakthrough After BMS?

#Orum Therapeutics, Inc. has reappointed a U.S. business development (BD) expert to its board of directors and expanded the limit on stock options granted to U.S. employees. At an investor briefing he…
2026-10-23 11:29:02